Value proposition

Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine.

Diatech Pharmacogenetics, the leading Italian Precision Medicine company.

Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine.
The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting.
The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding.
Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions to extract nucleic acids from patient samples, analyse them with the most advanced technologies and interpret them with the latest bioinformatic algorithms.

Excellence in each step of the diagnostic pipeline results in the personalisation of treatments, increased drug efficacy, reduced side-effects and ultimately better patient outcomes.

Pharmacogenetics, Pharmacogenomics, Tumour Biology, Diagnostics, DNA, RNA, FFPE, ctDNA, Cancer, NRAS, KRAS, BRAF, EGFR, ALK, MGMT, PI3K, IDH1-2, BRCA, R&D, and target therapy